UNSPSC 51422349: Fluprednisolone valerate

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H35FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PH7R4L7SNF, chemically known as 6alpha-fluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17-valerate but more generally known as fluprednisolone valerate, which bears US NIH Compound Identifier 31779. Most nations, for tariff and trade purposes, schedule fluprednisolone valerate under HS 29372200 and SITC 54153.

As of Q4 2014, FLUPREDNISOLONE VALERATE remains US FDA's Preferred Term for this commodity. Fluprednisolone valerate bears US NLM identifiers UMLS ID C2825344 and NCI Concept Code C80820. SMILES: CCCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2C[C@@H](C4=CC(=O)C=C[C@]34C)F)O)C)C(=O)CO.

UNSPSC 51422349 Fluprednisolone valerate is a Commodity code that shows minimal relevant recent state and local procurement activity. The single posted opportunity under this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and safe drug deactivation systems for community health delivery, a scope plainly unrelated to fluprednisolone valerate pharmaceutical procurement. The mismatch suggests either a tagging error in the state or local procurement system or a narrowly specialized use case that does not reflect typical buying patterns under this code.

No other recent opportunities in the source record support procurement of fluprednisolone valerate or establish a meaningful buying pattern across state and local jurisdictions. Without additional opportunities to characterize issuing-body mix, geographic spread, or representative work scope, this code presents insufficient signal to guide near-term business development strategy.